Literature DB >> 27838943

Does antenatal betamethasone have negative effects on fetal activities and hemodynamics in cases of preeclampsia without severe features? A prospective, placebo-controlled, randomized study.

Ilhan Bahri Delibas1, Metin Ingec2, Omer Erkan Yapca2.   

Abstract

AIM: To evaluate whether antenatal betamethasone affects the fetal biophysical profile (BPP) and Doppler indices of umbilical and middle cerebral arteries (MCAs) in cases of preeclampsia without severe features.
MATERIALS AND METHODS: Forty singleton preeclamptic pregnancies without severe features at gestational ages of 28-34 weeks were randomly divided into two groups of 20 patients: betamethasone and control groups. Patients in the betamethasone group were administered two consecutive doses of 12 mg betamethasone intramuscularly, 24 h apart, and patients in the control group were administered the same volume of saline as a placebo. All participants were evaluated before (0 h) and at hours 24, 48, and 72 of betamethasone/placebo administration using BPP scoring and umbilical and MCA Doppler examinations.
RESULTS: Total BPP scores were significantly lower in the betamethasone group across the three time points during the follow-up period (p < 0.001). None of the Doppler indices differed significantly between the groups (p > 0.05).
CONCLUSION: Antenatal betamethasone negatively affects fetal BPP score parameters, including the non-stress test, fetal body and breathing movements, without affecting vascular indices of umbilical arteries and MCAs. Clinician awareness of this transient drug-induced effect might be valuable for preventing iatrogenic preterm delivery for fetuses in preeclamptic pregnancies without severe features.

Entities:  

Keywords:  Doppler ultrasonography; Preeclampsia; betamethasone; biophysical profile; fetus

Mesh:

Substances:

Year:  2016        PMID: 27838943     DOI: 10.1080/14767058.2016.1261107

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis.

Authors:  Elizabeth Wastnedge; Joshua Vogel; Jasper V Been; Cynthia Bannerman-Gyamfi; Ewoud Schuit; Devender Roberts; Rebecca M Reynolds; Sarah Stock
Journal:  Wellcome Open Res       Date:  2020-02-25

2.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Emma McGoldrick; Fiona Stewart; Roses Parker; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2020-12-25

3.  Short-Term Effects of Dexamethasone versus Betamethasone on Ultrasonic Measures of Fetal Well-Being: Cohort from a Blinded, Randomized Trial.

Authors:  Amanda Henry; Aditi Mahajan; Caroline A Crowther; Anne Lainchbury; Lynne Roberts; Antonia W Shand; Alec W Welsh
Journal:  Fetal Diagn Ther       Date:  2021-07-28       Impact factor: 2.587

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.